Sanuwave Health Inc(SNWV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 16.63 | EPS (ttm) | 0.24 | Insider Own | 5.42% | Shs Outstand | 8.6M | Perf Week | -10.11% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | -20.83% | Shs Float | 8.1M | Perf Month | -27.27% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | 48.03% | Short Float | 3.74% | Perf Quarter | -72.18% |
| Income | 0.01B | P/S | 0.78 | EPS this Y | - | Inst Trans | -15.16% | Short Ratio | 1.54 | Perf Half Y | -82.01% |
| Sales | 0.04B | P/B | 12.35 | EPS next 5Y | - | ROA | 41.1% | Short Interest | 0.30M | Perf YTD | -86.6% |
| Book/sh | 0.32 | P/C | 3.67 | EPS past 3/5Y | - | ROE | - | 52W High | -90.21% ($40.87) | Perf Year | -88.63% |
| Cash/sh | 1.09 | P/FCF | 8.17 | Sales past 3/5Y | 38.05% 61.12% | ROIC | 80.01% | 52W Low | -0.5% ($4.02) | Perf 3Y | -46.4% |
| Dividend Est. | - | EV/EBITDA | 22.31 | EPS Y/Y TTM | 119.59% | Gross Margin | 73.96% | Volatility(W/M) | 6.44% 6.64% | Perf 5Y | -89.06% |
| Dividend TTM | - | EV/Sales | 1.04 | Sales Y/Y TTM | 12.02% | Oper. Margin | 1.54% | ATR (14) | 0.38 | Perf 10Y | -92.48% |
| Dividend Ex-Date | - | Quick Ratio | 0.89 | EPS Q/Q | -1216.9% | Profit Margin | 32.6% | RSI (14) | 24.31 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.28 | Sales Q/Q | -4.18% | SMA20 | -13.51% ($4.62) | Beta | 1.44 | Target Price | $40 |
| Payout | - | Debt/Eq | 7.42 | Earnings | 2026/8/6 | SMA50 | -37.66% ($6.42) | Rel Volume | 0.28 | Prev Close | $4.04 |
| Employees | 55 | LT Debt/Eq | 5.41 | EPS/Sales Surpr. | - | SMA200 | -78.08% ($18.25) | Avg Volume(3M) | 0.20M | Price | $4 |
| IPO | 2009/9/30 | Option/Short | No/Yes | Trades | 572 | Volume | 55,370 | Change | -0.99% |
Company
SNWV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩹 SanuWave Health (SNWV) is a U.S. medical device company focused on wound care and regenerative medicine. It develops and supplies treatment solutions targeting chronic wounds and tissue regeneration, and is a small healthcare company with hospitals and specialized wound care facilities as its primary customers.
Over the past 1 year, on the lower side
90% below its 1-year high.
SNWV has weak earning power
1.54% of revenue is kept as operating profit.
Tap to view numbers
The stock looks undervalued
Trading at 16.6 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -46.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 48.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
OMFS 0.00%
IWC 0.00%
GSSC 0.00%
IWO 0.00%
FLQS 0.00%It ranks #4 in the industry
Based on market cap of $34M.
SNWV $34M PER 16.6
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is SNWV?
SNWV belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SNWV?
The market cap of SNWV is approximately $34M, ranking 5,095 within its sector.
What is the P/E ratio of SNWV?
SNWV has a P/E ratio of approximately 16.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SNWV?
SNWV has recorded a 52-week high of $40.87 and a low of $4.02.
